Hjem › Tykktarmskreft › Florida › Jacksonville
Kliniske studier for Tykktarmskreft i Jacksonville, FL
9 studier for Tykktarmskreft søker deltakere på steder i og rundt Jacksonville (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
RekruttererFase 3
- Mayo Clinic in Florida ( Site 0092), Jacksonville
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RekruttererFase 3
- Mayo Clinic Pharmacy, Jacksonville
- Mayo Clinic, Jacksonville
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
RekruttererFase 2/3
- Baptist MD Anderson Cancer Center, Jacksonville
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
RekruttererFase 1
- Mayo Clinic Florida, Jacksonville
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
RekruttererFase 1
- Xencor Investigative Site, Jacksonville
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
RekruttererFase 1/2
- Mayo Clinic, Jacksonville
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Mayo Clinic in Florida, Jacksonville
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Jacksonville
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
RekruttererFase 1/2
- Mayo Clinic, Jacksonville
Tykktarmskreft-studier i andre byer
- Boston, MA22 studier
- New York City, NY22 studier
- Houston, TX20 studier
- Los Angeles, CA16 studier
- Nashville, TN16 studier
- St. Louis, MO15 studier
- Arlington, VA15 studier
- Chicago, IL14 studier
- San Antonio, TX14 studier
- Baldwin Park, CA14 studier
- Baltimore, MD13 studier
- Tampa, FL13 studier
Andre studier i Jacksonville
- Brystkreft40 studier
- Ikke-småcellet lungekreft39 studier
- Kreft (alle typer)29 studier
- Metastatisk kreft28 studier
- Kolorektal kreft27 studier
- Prostatakreft26 studier
- Fedme25 studier
- Hjertesvikt21 studier
- Pankreaskreft20 studier
- Overvekt19 studier
- Multipelt myelom18 studier
- Lungekreft17 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.